Genentech Welcomes Ashley Magargee as New CEO: A 20-Year Journey of Excellence and Leadership

Genentech shared today on LinkedIn:

“We are excited to share that Ashley Magargee has been appointed our Chief Executive Officer effective January 1, 2024.

Most recently Head of Commercial Portfolio, Ashley is a 20-year Roche and Genentech veteran with a deep commitment to our people, the patients we serve, and the stakeholders with whom we partner across the healthcare system.

Read more below. Congratulations, Ashley!”

More information here: https://www.gene.com/media/statements/ps_121223

Source: Genentech / LinkedIn